IMMUTEP LIMITED - AMER
2.0500
07-十月-24 14:59:57
15 分钟延时
股票
0.0000
0.00%
今日范围
2.0200 - 2.0900
ISIN
N/A
来源
NASDAQ
-
17 4月 2024 07:00:01 条件 Nasdaq GlobeNewswire
-
Immutep Announces First Clinical Data from 90mg Dosing of Efti
05 3月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report Q2 FY24
30 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
04 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
21 12月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Receives A$2.6 million R&D Tax Incentive from French Government
07 12月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial
22 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
09 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
06 11月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
03 11月 2023 11:00:00 条件 Nasdaq GlobeNewswire
-
Immutep to Participate in November Investor Events
02 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report Q1 FY24
31 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Immutep receives ~A$1.13 million R&D Tax Incentive
25 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023
24 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
23 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Announces Publication of Abstracts at ESMO Congress 2023
16 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
03 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
21 9月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Immutep to Participate in September Investor Conferences
05 9月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Receives Positive Scientific Advice from European Medicines Agency
01 8月 2023 07:00:02 条件 Nasdaq GlobeNewswire